Ovarian malignancy in breast cancer patients with an adnexal mass

Fiona Simpkins, Marianna Zahurak, Deborah Armstrong, Frances Grumbine, Robert Bristow

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

OBJECTIVE: The objectives of this study were to estimate ovarian malignancy rate in breast cancer patients with an adnexal mass and to identify variables predictive of malignancy. METHODS: This was a review from 1990-2002 including women with breast cancer diagnosed with an adnexal mass who subsequently underwent oophorectomy. Ovarian pathology was classified as benign, primary malignancy, or metastatic breast cancer. Women with preoperative evidence of malignancy were excluded. RESULTS: Of 129 cases reviewed, benign ovarian cysts were found in 113 cases (88%) and malignant ovarian neoplasms were found in 16 cases (12%). Univariate logistic regression analyses were performed to determine predictors of malignancy. Complex masses were 29 times more likely to be malignant (P < .001). Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003). Patients with an elevated CA 125 had a 6.3-fold increased risk of malignancy, P = .02. Adnexal mass size greater than 5 cm also increased the risk of malignancy (18.8%; OR 4.6, 95% confidence interval 1.2-17.3; P = .02). Malignant adnexal masses had a greater likelihood of being primary ovarian cancer than metastatic breast cancer by 7:1. CONCLUSION: An isolated adnexal mass in the breast cancer patient is most commonly a benign ovarian cyst. Adnexal masses associated with an increased CA 125, complex architecture by ultrasonography, or size greater than 5cm are significant predictors of malignancy and are indications for referral to a gynecologic oncologist.

Original languageEnglish
Pages (from-to)507-513
Number of pages7
JournalObstetrics and Gynecology
Volume105
Issue number3
DOIs
StatePublished - Mar 1 2005
Externally publishedYes

Fingerprint

Breast Neoplasms
Neoplasms
Ovarian Cysts
Ovarian Neoplasms
Confidence Intervals
Ovariectomy
Estrogen Receptors
Ultrasonography
Referral and Consultation
Logistic Models
Regression Analysis
Pathology

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Simpkins, F., Zahurak, M., Armstrong, D., Grumbine, F., & Bristow, R. (2005). Ovarian malignancy in breast cancer patients with an adnexal mass. Obstetrics and Gynecology, 105(3), 507-513. https://doi.org/10.1097/01.AOG.0000154162.51442.14

Ovarian malignancy in breast cancer patients with an adnexal mass. / Simpkins, Fiona; Zahurak, Marianna; Armstrong, Deborah; Grumbine, Frances; Bristow, Robert.

In: Obstetrics and Gynecology, Vol. 105, No. 3, 01.03.2005, p. 507-513.

Research output: Contribution to journalArticle

Simpkins, F, Zahurak, M, Armstrong, D, Grumbine, F & Bristow, R 2005, 'Ovarian malignancy in breast cancer patients with an adnexal mass', Obstetrics and Gynecology, vol. 105, no. 3, pp. 507-513. https://doi.org/10.1097/01.AOG.0000154162.51442.14
Simpkins, Fiona ; Zahurak, Marianna ; Armstrong, Deborah ; Grumbine, Frances ; Bristow, Robert. / Ovarian malignancy in breast cancer patients with an adnexal mass. In: Obstetrics and Gynecology. 2005 ; Vol. 105, No. 3. pp. 507-513.
@article{58a1cbc8a078421ab058beb0cf731cf4,
title = "Ovarian malignancy in breast cancer patients with an adnexal mass",
abstract = "OBJECTIVE: The objectives of this study were to estimate ovarian malignancy rate in breast cancer patients with an adnexal mass and to identify variables predictive of malignancy. METHODS: This was a review from 1990-2002 including women with breast cancer diagnosed with an adnexal mass who subsequently underwent oophorectomy. Ovarian pathology was classified as benign, primary malignancy, or metastatic breast cancer. Women with preoperative evidence of malignancy were excluded. RESULTS: Of 129 cases reviewed, benign ovarian cysts were found in 113 cases (88{\%}) and malignant ovarian neoplasms were found in 16 cases (12{\%}). Univariate logistic regression analyses were performed to determine predictors of malignancy. Complex masses were 29 times more likely to be malignant (P < .001). Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44{\%}; OR 12.4, 95{\%} confidence interval 2.4-65.1; P = .003). Patients with an elevated CA 125 had a 6.3-fold increased risk of malignancy, P = .02. Adnexal mass size greater than 5 cm also increased the risk of malignancy (18.8{\%}; OR 4.6, 95{\%} confidence interval 1.2-17.3; P = .02). Malignant adnexal masses had a greater likelihood of being primary ovarian cancer than metastatic breast cancer by 7:1. CONCLUSION: An isolated adnexal mass in the breast cancer patient is most commonly a benign ovarian cyst. Adnexal masses associated with an increased CA 125, complex architecture by ultrasonography, or size greater than 5cm are significant predictors of malignancy and are indications for referral to a gynecologic oncologist.",
author = "Fiona Simpkins and Marianna Zahurak and Deborah Armstrong and Frances Grumbine and Robert Bristow",
year = "2005",
month = "3",
day = "1",
doi = "10.1097/01.AOG.0000154162.51442.14",
language = "English",
volume = "105",
pages = "507--513",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Ovarian malignancy in breast cancer patients with an adnexal mass

AU - Simpkins, Fiona

AU - Zahurak, Marianna

AU - Armstrong, Deborah

AU - Grumbine, Frances

AU - Bristow, Robert

PY - 2005/3/1

Y1 - 2005/3/1

N2 - OBJECTIVE: The objectives of this study were to estimate ovarian malignancy rate in breast cancer patients with an adnexal mass and to identify variables predictive of malignancy. METHODS: This was a review from 1990-2002 including women with breast cancer diagnosed with an adnexal mass who subsequently underwent oophorectomy. Ovarian pathology was classified as benign, primary malignancy, or metastatic breast cancer. Women with preoperative evidence of malignancy were excluded. RESULTS: Of 129 cases reviewed, benign ovarian cysts were found in 113 cases (88%) and malignant ovarian neoplasms were found in 16 cases (12%). Univariate logistic regression analyses were performed to determine predictors of malignancy. Complex masses were 29 times more likely to be malignant (P < .001). Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003). Patients with an elevated CA 125 had a 6.3-fold increased risk of malignancy, P = .02. Adnexal mass size greater than 5 cm also increased the risk of malignancy (18.8%; OR 4.6, 95% confidence interval 1.2-17.3; P = .02). Malignant adnexal masses had a greater likelihood of being primary ovarian cancer than metastatic breast cancer by 7:1. CONCLUSION: An isolated adnexal mass in the breast cancer patient is most commonly a benign ovarian cyst. Adnexal masses associated with an increased CA 125, complex architecture by ultrasonography, or size greater than 5cm are significant predictors of malignancy and are indications for referral to a gynecologic oncologist.

AB - OBJECTIVE: The objectives of this study were to estimate ovarian malignancy rate in breast cancer patients with an adnexal mass and to identify variables predictive of malignancy. METHODS: This was a review from 1990-2002 including women with breast cancer diagnosed with an adnexal mass who subsequently underwent oophorectomy. Ovarian pathology was classified as benign, primary malignancy, or metastatic breast cancer. Women with preoperative evidence of malignancy were excluded. RESULTS: Of 129 cases reviewed, benign ovarian cysts were found in 113 cases (88%) and malignant ovarian neoplasms were found in 16 cases (12%). Univariate logistic regression analyses were performed to determine predictors of malignancy. Complex masses were 29 times more likely to be malignant (P < .001). Women with estrogen-receptor-negative breast cancer had an increased risk for malignant adnexal masses (44%; OR 12.4, 95% confidence interval 2.4-65.1; P = .003). Patients with an elevated CA 125 had a 6.3-fold increased risk of malignancy, P = .02. Adnexal mass size greater than 5 cm also increased the risk of malignancy (18.8%; OR 4.6, 95% confidence interval 1.2-17.3; P = .02). Malignant adnexal masses had a greater likelihood of being primary ovarian cancer than metastatic breast cancer by 7:1. CONCLUSION: An isolated adnexal mass in the breast cancer patient is most commonly a benign ovarian cyst. Adnexal masses associated with an increased CA 125, complex architecture by ultrasonography, or size greater than 5cm are significant predictors of malignancy and are indications for referral to a gynecologic oncologist.

UR - http://www.scopus.com/inward/record.url?scp=13944278090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13944278090&partnerID=8YFLogxK

U2 - 10.1097/01.AOG.0000154162.51442.14

DO - 10.1097/01.AOG.0000154162.51442.14

M3 - Article

VL - 105

SP - 507

EP - 513

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -